MYCO.NE - Mydecine Innovations Group Inc.

Cboe CA - Cboe CA Real Time Price. Currency in CAD
Currency in CAD

Valuation Measures4

Market Cap (intraday) 5.61M
Enterprise Value 10.06M
Trailing P/E 8.00
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)567.17
Price/Book (mrq)N/A
Enterprise Value/Revenue 1.59k
Enterprise Value/EBITDA -0.55

Trading Information

Stock Price History

Beta (5Y Monthly) 3.34
52-Week Change 3-75.81%
S&P500 52-Week Change 34.08%
52 Week High 31.0300
52 Week Low 30.1900
50-Day Moving Average 30.4722
200-Day Moving Average 30.5523

Share Statistics

Avg Vol (3 month) 3108.71k
Avg Vol (10 day) 375.37k
Shares Outstanding 524.94M
Implied Shares Outstanding 6N/A
Float 824.01M
% Held by Insiders 15.58%
% Held by Institutions 10.00%
Shares Short (Mar 14, 2021) 436.97k
Short Ratio (Mar 14, 2021) 40.76
Short % of Float (Mar 14, 2021) 4N/A
Short % of Shares Outstanding (Mar 14, 2021) 41.05%
Shares Short (prior month Feb 11, 2021) 491.7k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:50
Last Split Date 3Apr 20, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-261.05%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -15.49M
Net Income Avi to Common (ttm)-19.26M
Diluted EPS (ttm)-0.4400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)565.71k
Total Cash Per Share (mrq)0.02
Total Debt (mrq)5.02M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.33
Book Value Per Share (mrq)-0.37

Cash Flow Statement

Operating Cash Flow (ttm)-9.81M
Levered Free Cash Flow (ttm)-7.22M